Medical and Pharmaceutical Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test The FDA grants Breakthrough Device designation to devices that may offer more effective treatment or diagnosis of serious conditions like cancer Joseph Morton14 hours ago
Medical and Pharmaceutical Australian biotech uncovers broader view of tumour genetics with liquid biopsy The team developed the study in collaboration with US sequencing company Illumina Joseph MortonJune 17, 2025
Medical and Pharmaceutical DNA blood biopsy to identify personalized treatments for lung cancer patients Thousands in the UK will soon benefit from the state-of-the-art test developed by Guardant Health Rowan DunneMay 30, 2025
Medical and Pharmaceutical New Korean cancer tech finds mutations with only a few drops of blood In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations Joseph MortonFebruary 18, 2025
Health & Wellness Grail shares jump on partnership with Quest Diagnostics The test operates on the principle that cancers shed DNA into the bloodstream Joseph MortonFebruary 14, 2025
AI and Autonomy Korean medical technology company incorporates AI into lung cancer diagnosis Japan has a critical shortage of radiologists, despite a population double the size of Korea's Joseph MortonFebruary 3, 2025
Medical and Pharmaceutical Lung cancer isn’t just for smokers anymore: European study The study analyzed CT scans from over 10,000 participants and found at least one lung nodule in 42 per cent of them Joseph MortonOctober 2, 2024